Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Name: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)
Published: 2013
License: Public Domain

Gilead Sciences · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

chronic hepatitis c virus, hcv genotype 1 (gt-1), hcv, sustained virologic response, direct acting antiviral, combination therapy, gs-7977, gs-5885, ribavirin, open label, sofosbuvir, additional relevant mesh terms:

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 851349
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.